Sometimes, it makes sense for a medtech company to outsource product development to bring their device to market faster and more efficiently. MassDevice.com editor Sarah Faulkner spoke to Minnetronix‘s VP of business development and marketing, Jim Reed, about how and when medtech companies should consider outsourcing product development to a partner. Faulkner: How should companies […]
While pharmaceutical companies and medical device firms know that working together is a vital part of doing business, they “live in 2 different world in many ways,” Minnetronix co-founder Dirk Smith said last week at the annual Drug Delivery Partnerships conference. From development timelines to regulatory approval pathways, it can sometimes seem like pharma and medtech companies are […]
BioSig Technologies (OTCQB: BSGM) issued a letter to its shareholders today, updating them on the company’s recent developments and revealing that it tapped Minnetronix to develop the 1st version of its Pure EP system. The Minneapolis-based company is developing a cardiac signal acquisition and display system which is designed to assist electrophysiologists in making clinical decisions for patients with […]
Minnetronix said yesterday it raised $20 million in equity capital through a minority investment from Altaris Capital Partners. The investment marks the 1st time Minnetronix has raised outside equity since its founding 20 years prior. “Our team at Minnetronix is passionate about improving patients’ lives. We’ve developed technologies large and small through the years and […]
Fujifilm Holdings (TSE:4901) said its Fujifilm Medical Systems U.S.A. subsidiary lured an Accuray (NSDQ:ARAY) executive and a physician from the University of Southern California to its executive roster effective Sept. 28. The Stamford, Conn.-based company said Johann Fernando, formerly Accuray’s vice president & general manager, was named to be its operations chief. Dr. Diku Mandavia, who has […]
The medical device business landscape is changing rapidly in response to a wide range of socioeconomic and government pressures. As the U.S. population continues to age, by 2030 20% of U.S. residents will be over 65, compared with 13% in 2010 and 9.8% in 1970, the demand for better and more cost-effective medical care is […]
Medical device maker Minnetronix touted its acquisition of privately held Neurofluidics, a company developing treatment for neurological disorders. The details of the merger were not disclosed.
California-based Neurofluidics became a subsidiary of Minnetronix, which Minnetronix president & CEO Rich Nazarian called a "natural fit."
New Minnetronix CFO started yesterday
The new CFO of Minnetronix, Phil Ankeny, joined the company today. Ankeny moved over to Minnetronix from SurModics Inc., where he served as interim CEO and CFO. His background is in venture capital, IT startups and investment banking.
AngioDynamics Inc. (NSDQ:ANGO) named a replacement for former CEO Jan Keltjens, who left suddenly in June, tapping Joseph DeVivo for the corner office.
The Latham, N.Y.-based oncology device company also revealed the resignation of senior vice president of business development Lynda Wallace, according to SEC filings.
Neoprobe Corp. (NYSE Amex:NEOP) is getting a new chief executive and, perhaps, a new board member.
The Dublin, Ohio-based cancer diagnostics firm announced that CEO David Bupp will be replaced by chief development officer Mark Pykett on April 15.